ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Bio-Techne Corp

Bio-Techne Corp (1TECH)

0,00
0,00
(0,00%)
Geschlossen 14 Juni 5:30PM

Bio-Techne Corp (1TECH) Insidergeschäfte

-
Filtern nach:
Datum Name des Inhabers Gehandelte Aktien Wertspanne ($) Transaktionstyp Preisspanne ($) Aktien am Meldungsende % Veränderung
2026-06-02Mr. Steven C. CrousePresident of Diagnostics and Spatial Biology Segment-216,0010,75kDerivative Exercise and Sale49,776,76k-
2026-06-02Mr. Steven C. CrousePresident of Diagnostics and Spatial Biology Segment384,000,00Derivative Exercise and Retained Stock-6,76k6,02%
2026-05-08Dr. Amy E. HerrIndependent Director-6,64k4,51kDerivative Exercise and Sale47,60 - 48,282,88k-
2026-05-05Mr. James T. HippelExec. VP of Finance & CFO-56,96k517,15kDerivative Exercise and Sale47,60 - 56,68153,67k-
2026-05-05Mr. James T. HippelExec. VP of Finance & CFO5,05k240,14kDerivative Exercise and Retained Stock47,60153,67k3,39%
2026-05-05Mr. Shane BohnenSenior VP, General Counsel, Corporate Secretary & Chief Sustainability Officer-7,06k64,06kDerivative Exercise and Sale47,60 - 56,687,25k-
2026-05-05Mr. Shane BohnenSenior VP, General Counsel, Corporate Secretary & Chief Sustainability Officer1,35k64,02kDerivative Exercise and Retained Stock47,607,25k22,78%
2026-05-05Mr. Kim KeldermanCEO, President & Director-23,95k217,48kDerivative Exercise and Sale47,60 - 56,6865,80k-
2026-05-05Mr. Kim KeldermanCEO, President & Director2,74k130,47kDerivative Exercise and Retained Stock47,6065,80k4,35%
2026-05-01Mr. Steven C. CrousePresident of Diagnostics and Spatial Biology Segment-311,0017,11kDerivative Exercise and Sale55,026,34k-
2026-05-01Mr. Steven C. CrousePresident of Diagnostics and Spatial Biology Segment483,000,00Derivative Exercise and Retained Stock-6,34k8,25%
2026-04-22Mr. Kim KeldermanCEO, President & Director-1,36k79,84kDerivative Exercise and Sale58,5863,06k-
2026-04-22Mr. Kim KeldermanCEO, President & Director9,98k0,00Derivative Exercise and Retained Stock-63,06k18,80%
2026-04-22Mr. James T. HippelExec. VP of Finance & CFO-56,10k3,29MDerivative Exercise and Sale58,58148,63k-
2026-04-22Mr. James T. HippelExec. VP of Finance & CFO5,90k0,00Derivative Exercise and Retained Stock-148,63k4,14%
2026-04-14Mr. Kim KeldermanCEO, President & Director-32,09k1,88MDerivative Exercise and Sale58,6653,08k-
2026-04-14Mr. Kim KeldermanCEO, President & Director4,41k0,00Derivative Exercise and Retained Stock-53,08k9,07%
2026-04-03Mr. Shane BohnenSenior VP, General Counsel, Corporate Secretary & Chief Sustainability Officer-740,0039,32kDerivative Exercise and Sale53,135,90k-
2026-04-03Mr. Shane BohnenSenior VP, General Counsel, Corporate Secretary & Chief Sustainability Officer1,52k0,00Derivative Exercise and Retained Stock-5,90k34,64%
2026-02-17Dr. Amy E. HerrIndependent Director-1,98k116,79kVerkauf59,112,88k-40,69%
2026-02-03Dr. Amy E. HerrIndependent Director22,000,00Derivative Exercise and Retained Stock-4,86k0,46%
2026-02-03Dr. Amy E. HerrIndependent Director-16,001,03kDerivative Exercise and Sale64,634,86k-
2026-02-01Dr. Matthew F. McManusInsider2,96k0,00Derivative Exercise and Retained Stock-7,69k62,43%
2026-02-01Dr. Matthew F. McManusInsider-1,67k106,71kDerivative Exercise and Sale64,097,69k-
2025-11-03Mr. James T. HippelExec. VP of Finance & CFO12,84k0,00Derivative Exercise and Retained Stock-142,72k9,89%
2025-11-03Mr. James T. HippelExec. VP of Finance & CFO-11,87k742,39kDerivative Exercise and Sale62,57142,72k-
2025-11-03Mr. Kim KeldermanCEO, President & Director-2,30k144,10kSale to Issuer62,5748,67k-4,52%
2025-11-03Mr. William A. GeistPresident of Protein Sciences Segment5,39k0,00Derivative Exercise and Retained Stock-20,50k35,67%
2025-11-03Mr. William A. GeistPresident of Protein Sciences Segment-4,52k282,82kDerivative Exercise and Sale62,5720,50k-
2025-08-25Dr. Roeland NusseInsider-17,04k588,23kDerivative Exercise and Sale21,84 - 56,3644,56k-
2025-08-25Mr. Robert V. BaumgartnerIndependent Chairman of the Board-17,04k585,66kDerivative Exercise and Sale21,84 - 56,2144,86k-
2025-08-15Mr. James T. HippelExec. VP of Finance & CFO2,08k0,00Derivative Exercise and Retained Stock-129,88k1,63%
2025-08-15Mr. James T. HippelExec. VP of Finance & CFO-1,93k103,23kDerivative Exercise and Sale53,60129,88k-
2025-08-15Mr. Kim KeldermanCEO, President & Director4,24k0,00Derivative Exercise and Retained Stock-50,97k9,07%
2025-08-15Mr. Kim KeldermanCEO, President & Director-4,31k230,75kDerivative Exercise and Sale53,6050,97k-
2025-08-15Dr. Amy E. HerrIndependent Director178,000,00Derivative Exercise and Retained Stock-3,19k5,90%
2025-08-15Dr. Amy E. HerrIndependent Director-101,005,41kDerivative Exercise and Sale53,603,19k-
2025-08-15Mr. William A. GeistPresident of Protein Sciences Segment1,82k0,00Derivative Exercise and Retained Stock-15,11k13,69%
2025-08-15Mr. William A. GeistPresident of Protein Sciences Segment-803,0043,04kDerivative Exercise and Sale53,6015,11k-
2025-08-15Dr. Matthew F. McManusInsider1,76k0,00Derivative Exercise and Retained Stock-4,74k59,00%
2025-08-15Dr. Matthew F. McManusInsider-880,0047,17kDerivative Exercise and Sale53,604,74k-
2025-08-15Mr. Shane BohnenSenior VP, General Counsel, Corporate Secretary & Chief Sustainability Officer1,19k0,00Derivative Exercise and Retained Stock-4,39k37,29%
2025-08-15Mr. Shane BohnenSenior VP, General Counsel, Corporate Secretary & Chief Sustainability Officer-527,0028,25kDerivative Exercise and Sale53,604,39k-
2025-08-07Mr. John L. HigginsIndependent Director5,04k110,07kDerivative Exercise and Retained Stock21,8465,24k8,37%
2025-07-29Mr. James T. HippelExec. VP of Finance & CFO21,19k939,31kDerivative Exercise and Retained Stock44,33127,80k19,88%
2025-07-29Mr. James T. HippelExec. VP of Finance & CFO-147,43k2,10MDerivative Exercise and Sale44,33 - 58,55127,80k-
2025-07-22Mr. Kim KeldermanCEO, President & Director4,53k200,68kDerivative Exercise and Retained Stock44,3346,73k10,73%
2025-07-22Mr. Kim KeldermanCEO, President & Director-43,65k383,67kDerivative Exercise and Sale44,33 - 53,1246,73k-
2025-07-15Mr. Kim KeldermanCEO, President & Director3,20k141,81kDerivative Exercise and Retained Stock44,3342,20k8,20%
2025-07-15Mr. Kim KeldermanCEO, President & Director-32,93k233,49kDerivative Exercise and Sale44,33 - 51,4242,20k-

Kürzlich von Ihnen besucht

Delayed Upgrade Clock